Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. announced that shareholder Yang Zongmeng plans to reduce his shareholding by no more than 10.3657 million shares, accounting for 1% of the company's total share capital; Wang Haibo plans to reduce his shareholding by no more than 6.2 million shares, accounting for 0.60% of the company's total share capital. The method of reduction will be a centralized auction trade, and the period for the reduction will be from December 6, 2024, to March 5, 2025. The reduction price will not be lower than 8.67 yuan per share.
复旦张江：股东拟减持不超1.6%股份
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.: Shareholders plan to reduce their shareholding by no more than 1.6%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated